Skip to content

Preventing Falls Among Older Fallers to Test the Effect of LIVE-LiFE, a Home-Based, Tailored Fall Prevention Program

SAFE-LiFE to Prevent Falls Among Older Fallers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03351413
Acronym
LIVE-LiFE
Enrollment
40
Registered
2017-11-22
Start date
2017-07-01
Completion date
2019-08-01
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fall Prevention

Keywords

Fall Prevention, Older Adults

Brief summary

Purpose: To test the effect of LIVE-LiFE, a home-based, tailored fall prevention program for older adults with a high risk for falling. Study Type: Single-blind, two group randomized pilot trial. Randomization is 2:1 (27 intervention, 13 control). Participants have a chance of being in the LIVE-LiFE group or the control group. Safe-LiFE Group: Individually tailored intervention at the participant's home spaced across 12 weeks including: * Home safety assessment and risk reduction strategies; incorporating strength and balance training into daily habits vision screening and referral; and education about fear of falling and falls * Home repairs, modifications, and low cost assistive devices to address unsafe home environments increasing fall risk * Medication review and feedback concerning medications with increased fall risk Control Group: • An individualized fall risk assessment provided to participant and their primary care provider Sample: 40 community-dwelling older adults in Baltimore City or County

Interventions

OTHERLIVE-LiFE to Prevent Falls Among Older Fallers

LIVE-LiFE Intervention: Individually tailored program at the participant's home spaced across 12 weeks including: * Home safety assessment and risk reduction strategies; incorporating strength and balance training into daily habits vision screening and referral; and education about fear of falling and falls * Home repairs, modifications, and low cost assistive devices to address unsafe home environments increasing fall risk * Medication review and feedback concerning medications with increased fall risk Measurement intervals: Baseline, 4 months, 8 months (with $25 gift card given at each visit for your time)

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Single-blind, two group randomized pilot trial. Randomization is 2:1 (27 intervention, 13 control). Participants have a chance of being in the LIVE-LiFE group or the control group.

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults ≥ 70 or older * Self-report of 2 or more falls in the past 12 months OR 1 fall causing injury in the past 12 months

Exclusion criteria

* Moderate-severe memory problems * No conversational English * Not able to stand * Resident in a nursing home or assisted living facility * Hospitalized \> 3 times in the last year * Terminally ill (\<1 year expected survival) * Receiving active cancer treatment

Design outcomes

Primary

MeasureTime frameDescription
Times Up and Go TestBaseline to 16 weeksA test used to assess the length of time it takes a person to get out of a chair, walk 10 feet, turn around and sit back down in the same chair.

Secondary

MeasureTime frameDescription
Falls Self-EfficacyBaseline to 16 weeksThe confidence a person has in their ability to walk without falling measured via a 10-item Likert -type 10-point scale with score ranges from 10-100, where 10 is low confidence and 100 is high confidence in their ability to perform various activities without falling.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026